科兴制药: 关于2024年年度权益分派实施后调整回购价格上限的公告

Core Viewpoint - The company has adjusted the maximum repurchase price of its shares from RMB 46.83 per share to RMB 46.75 per share following the implementation of the 2024 annual equity distribution [1][3]. Summary by Sections Share Repurchase Basic Information - The company approved a share repurchase plan on March 17, 2025, allowing for a minimum repurchase amount of RMB 30 million and a maximum of RMB 60 million through the Shanghai Stock Exchange [1][4]. - The repurchased shares will be used for employee stock ownership plans or equity incentives and must be transferred within three years after the announcement of the repurchase results [1][4]. Reason for Adjusting the Maximum Repurchase Price - The adjustment in the repurchase price is based on the company's 2024 annual profit distribution plan, which includes a cash dividend of RMB 0.80 per 10 shares [2][3]. - The record date for the equity distribution is June 11, 2025, and the ex-dividend date is June 12, 2025 [2][3]. Details of the Price Adjustment - The new maximum repurchase price is calculated as follows: (previous maximum price - cash dividend) / (1 + change in circulating shares ratio) [3]. - Since the company is only distributing cash dividends and not changing the capital structure, the circulating shares ratio remains 0, leading to an adjusted maximum repurchase price of approximately RMB 46.75 per share [3][4]. Other Matters - Aside from the price adjustment, all other aspects of the share repurchase plan remain unchanged, and the company will comply with relevant regulations during the repurchase period [4].